Seo-Hee Rha

Seo-Hee Rha

Auto-generated profile, based on publicly available information

Seo-Hee Rha

Department of Pathology, Dong-A University, Busan 49315, Republic of Korea

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2009 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
Won Suk AnWon Suk An
Won Suk An
YSYoung Ki Son
Young Ki Son
SKSeong-Eun Kim
Seong-Eun Kim
KKKi-Hyun Kim
Ki-Hyun Kim
SYSeong Kuk Yoon
Seong Kuk Yoon
SRSeo-Hee Rha
Seo-Hee Rha

28 January 2020 in Cancers
Verified
Journal Article
Open access
PDF file
SISun-Wha Im
Sun-Wha Im
CSChang Ohk Sung
Chang Ohk Sung
KKKun Suk Kim
Kun Suk Kim
NCNamhoon Cho
Namhoon Cho
YKYoung Min Kim
Young Min Kim
YCYong Mee Cho
Yong Mee Cho
Due to the rare occurrence of young-onset bladder cancer (YBC), its genomic characteristics remain largely unknown. Twenty-nine biopsy-proven YBC cases were collected using a nation-wide search for bladder cancer diagnosed at 20 years or younger. Whole exome sequencing and RNA sequencing were carried out in 21 and 11 cases, respectively, and compared with those of adult bladder cancer (ABC) cases obtained from public databases. Almost all YBCs were low grade, non-invasive papillary tumors. YBC had a low mutation burden and less complex copy number alterations. All cases harbored putative driver mutations. Mutations were most commonly found in HRAS (10 cases), with a preference for exon 5. FGFR3 gene fusions were noted with various partner genes (7 cases). The alterations on HRAS and FGFR3 occurred in a mutually exclusive manner. Others included KRAS mutations (2 cases), chromosomes 4p and 10q arm-level deletions (1 case), and ERCC2 mutation (1 case). There were no point mutations in TP53 and FGFR3. The gene expression profiles of YBC were similar to those of the ABC group with good prognosis. None of the YBCs and ABCs with YBC-like mutations showed progression to muscle-invasive tumors. Our results suggest that bladder cancer with YBC-like mutations represents an indolent bladder tumor, regardless of age.

10 January 2025 in Medicine
Verified
Journal Article
Open access
SPSoyoung Park
Soyoung Park
JPJung-Woo Park
Jung-Woo Park
SRSeo-Hee Rha
Seo-Hee Rha
SKSujin Kim
Sujin Kim
Rationale: Malignant melanoma is a rare cancer that accounts for approximately 1% of all cancers. Primary malignant melanoma of the female genital tract accounts for approximately 3% to 7% of all malignant melanomas, and 0.3% to 0.8% of all melanomas in women. It affects postmenopausal women ages 60 to 80 years. Various hormonal factors, including puberty, pregnancy, menopause, oral contraceptive use, and human papillomavirus infection are associated with primary malignant melanoma of the vagina. Patient concerns: Symptoms often include vaginal bleeding, discharge, and pain; however, it can also present as pigmented or nonpigmented lesions, making diagnosis challenging. Diagnoses: Diagnosis involves detailed history, physical examination, and imaging (CT, MRI, and positron emission tomography). Immunohistochemical staining for markers, such as human melanoma black-45 and Melan-A, is crucial for confirmation. The diagnosis was made through careful physical examination, imaging studies, and immunohistochemistry. Interventions: The treatment includes wide local excision, radical surgery, radiotherapy, chemotherapy, and immunotherapy. The prognosis of primary malignant melanoma of the vagina is usually poor owing to late diagnosis, and the 5-year survival rate is 5% to 25%. Outcomes and lessons: To consider the possibility of primary malignant melanoma of vagina, postmenopausal women, particularly those who with human papillomavirus infection, should be performed thorough examination regardless of symptoms of vaginal bleeding or discharge.

25 October 2022 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
JSJae-Ryong Shim
Jae-Ryong Shim
MKMiri Kang
Miri Kang
KWKwang-Sook Woo
Kwang-Sook Woo
SRSeo-Hee Rha
Seo-Hee Rha
JHJin-Yeong Han
Jin-Yeong Han
Jae-Ryong Shim, M.D., Miri Kang, M.T., Kwang-Sook Woo, M.D., Seo-Hee Rha, M.D., and Jin-Yeong Han, M.D.. Ann Lab Med 2023;43:208-10. https://doi.org/10.3343/alm.2023.43.2.208

1 January 2024 in Journal of the Korean Society of Radiology
Verified
Journal Article
Open access
PDF file
SBSang Bin Bae
Sang Bin Bae
SYSeong Kuk Yoon
Seong Kuk Yoon
SRSeo-Hee Rha
Seo-Hee Rha
배상빈, et al. J Korean Soc Radiol. 2024 Jan;85(1):222-229. https://doi.org/10.3348/jksr.2023.0076

25 December 2024 in Korean Journal of Otorhinolaryngology-Head and Neck Surgery
Verified
Journal Article
Open access
PDF file
YYYoung Bin Yun
Young Bin Yun
HLHyung-Geun Lee
Hyung-Geun Lee
SRSeo Hee Rha
Seo Hee Rha
DLDong Kun Lee
Dong Kun Lee
Myxoma is a benign tumor of mesenchymal origin that most commonly arises in the heart. It can arise in various sites including the subcutaneous tissue, bone, skin, and muscles. Myxomas in the head and neck region predominantly occur in the maxilla or mandible, accounting for 76% of the cases, while occurrences in the soft tissues are extremely rare. The floor of the mouth in the head and neck region is the rarest site for the occurrence of soft tissue myxomas. In the international literature, only two cases have been reported, and there have been no reported cases in the domestic literature. In this paper, we report, with a review of literatures, a case of a 74-year-old female patient who presented with a mass lesion found beneath the left mandible and was finally diagnosed with a myxoma.